Cargando…
Magnetic levitation pumps for cell-free hemoglobin prevention during VV ECMO
Autor principal: | Condello, Ignazio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966283/ https://www.ncbi.nlm.nih.gov/pubmed/35351168 http://dx.doi.org/10.1186/s13054-022-03963-9 |
Ejemplares similares
-
ECMO and CRRT “All in One!” in COVID-19 Era
por: Condello, Ignazio, et al.
Publicado: (2023) -
Contrast Echocardiography in VV-ECMO-Dependent Patients with COVID-19
por: Bleakley, Caroline, et al.
Publicado: (2020) -
Magnetic levitation pump versus constrained vortex pump: a pilot study on the hemolysis effect during minimal invasive extracorporeal circulation
por: Condello, Ignazio, et al.
Publicado: (2021) -
VV-ECMO usage in ARDS due to COVID-19: Clinical, practical and ethical considerations
por: Hoyler, Marguerite M., et al.
Publicado: (2020) -
The role of cell-free hemoglobin and haptoglobin in acute kidney injury in critically ill adults with ARDS and therapy with VV ECMO
por: Graw, Jan A., et al.
Publicado: (2022)